|
|
| | DOTA Zoledronate Basic information |
| Product Name: | DOTA Zoledronate | | Synonyms: | DOTA Zoledronate;1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, 10-[2-[[2-[1-(2-hydroxy-2,2-diphosphonoethyl)-1H-imidazol-4-yl]ethyl]amino]-2-oxoethyl]-;Gadobutrol Impurity 76;2,2,2-(10-(2-((2-(1-(2-hydroxy-2,2-diphosphonoethyl)-1H-imidazol-4-yl)ethyl)amino)-2-oxoethyl)-1,4,7,10-tetrazacyclododecane-1,4,7-triyl)triacetic acid | | CAS: | 1908409-18-6 | | MF: | C23H41N7O14P2 | | MW: | 701.56 | | EINECS: | | | Product Categories: | | | Mol File: | 1908409-18-6.mol |  |
| | DOTA Zoledronate Chemical Properties |
| density | 1.68±0.1 g/cm3(Predicted) | | solubility | Methanol (Slightly), Water (Slightly) | | pka | 1.41±0.10(Predicted) | | form | Solid | | color | White to Off-White | | Stability: | Hygroscopic |
| | DOTA Zoledronate Usage And Synthesis |
| Uses | DOTA Zoledronate is a reactant used in the therapy of bone diseases interacting with metal isotopes and undergoing chelation. |
| | DOTA Zoledronate Preparation Products And Raw materials |
|